相关实验视频
Updated: May 11, 2026

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.3K
改变世界:5年心脏外科跨社会联盟 (CSIA)
R M Bolman1, P Zilla2, F Beyersdorf3
1Division of Cardio-Thoracic Surgery, Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
概括
心脏外科协会联盟 (CSIA) 在莫桑比克和卢旺达建立了试点项目,以建立可持续的心脏外科能力. 这些举措成功地增加了病例数量和政府承诺,改善了发展中国家获得护理的机会.
科学领域:
- 全球健康 全球健康
- 心血管外科心血管外科
- 发展中国家经济体的发展.
背景情况:
- 发展中国家心脏外科手术的大量未满足需求需要全球合作.
- 开普敦宣言强调了人们在获得心脏手术护理方面的差异.
- 心脏外科协会联盟 (CSIA) 是为了解决这种差异而成立的.
研究的目的:
- 在低收入国家建立和评估可持续的,本地心脏手术能力.
- 通过需求评估和提案流程,识别和支持新兴的心脏手术项目.
- 改善缺乏服务的人群获得必要的心脏外科手术的机会.
主要方法:
- 全球需要评估,以确定流行病理,确认风湿性心脏病作为主要关注点.
- 根据政府和机构的支持,选择莫桑比克和卢旺达作为试点地点.
- 实施指导和培训协议,包括虚拟会议和现场支持,使用"仅提供协助"协议.
主要成果:
- 在莫桑比克和卢旺达成功建立了五年内心脏手术项目.
- 病例数量明显增加,政府承诺加强,试点站点基础设施升级.
- CSIA的"批准印章"促进了行业捐款和与全球捐助者谈判以获得进一步的资金.
结论:
- CSIA模型有效地促进了发展中国家的可持续心脏手术能力建设.
- 国际合作和有针对性的指导对于改善心脏手术护理的准入至关重要.
- 扩大CSIA Seal计划可以进一步加强全球在当地心脏手术发展方面的努力.
更多相关视频
相关概念视频
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

